Metabolic syndrome: clinical perspective for best practice
Darin Olde1, Patricia Alpert, Alona Dalusung-Angosta
1Silver Sage Center for Family Medicine, Reno, Nevada.
Journal of the American Association of Nurse Practitioners
|October 31, 2013
Summary
Metabolic syndrome (MetS) increases risks for diabetes and cardiovascular disease. Advanced practice nurses play a key role in MetS management and ethical care.
Area of Science:
- Endocrinology and Nursing Science
Background:
- Metabolic syndrome (MetS) is a cluster of conditions including hypertension, high blood sugar, unhealthy cholesterol levels, and excess abdominal fat.
- It significantly elevates the risk for developing type 2 diabetes and cardiovascular diseases.
Observation:
- Current research explores the intricate pathophysiology of MetS, involving environmental factors, genetic predisposition, insulin resistance, and adipose tissue dysfunction.
- The exact mechanisms underlying MetS are still under investigation.
Findings:
- Metabolic syndrome is characterized by a combination of risk factors that predispose individuals to serious health conditions.
- The complex interplay of genetics, environment, and metabolic dysfunction contributes to MetS development.
Implications:
- Advanced practice nurses are crucial for early intervention, patient counseling, and managing the ethical dimensions of care for individuals with MetS.
- Their role extends to educating at-risk populations and addressing the multifaceted challenges in MetS patient management.
Related Concept Videos
01:26Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
32
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:24Type II Diabetes II: Pathophysiology
45
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
45
01:24Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747